Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Good News

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 30, 2020 11:55am

188 Views

Post# 32197576

RE:RE:RE:RE:RE:Good News

MrMugsy wrote:

themagicbox wrote: Not to mention the new research coming out of the "university-that-cannot-be-named" discussed in the latest biopub. That will create both new IP and new patents that go far beyond the data protection and organge book patents for Oten/346.

The wild card will be what comes from the research on covid and if the different pipeline drugs have a therapeutic effect on COVID

I find COVID to be an interesting topic based on a few facts ...
1. They can't discuss details (other than an NDA, what other reason?). Could there be a partnership on this side.
2. Antibe is looking to get deeper into gaseous mediators and this alone spells exciting new approaches to dealing with inflamation, the root cause in some respects.
3. Think viruses and think gaseous mediators and I'm picturing opportunities for any virus down the road - even the common flu ????? Ya ya ... I'm dreaming - but Wallace has a chance to live his dream ... right here ... right now !!!!
4. https://journals.physiology.org/doi/full/10.1152/ajpcell.00187.2020

Wonderdrug possibilites? I think one day we will look at gaseous mediators and say - what took us so long to get here ? Fingers crossed.

Oh ... as the article leads into ... even repairing damage to lungs. That gets us back full circle to OTENA and the reduction in ulceration. Next step after that ... repairing stomach ulcers. None of this is beyond ATE's abilities and ... I would bet ... Wallace has already travelled quite a distance down this road, with his iron sucking drugs to reduce pain associated with IBD.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December